Evoke Wealth’s Zymeworks ZYME Stock Holding History

Evoke Wealth’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,179	Closed	-$200K	–	1267
2021 Q4	$200K	Hold	12,179	–	–	0.01%	362
2021 Q3	$353K	Hold	12,179	–	–	0.01%	267
2021 Q2	$422K	Hold	12,179	–	–	0.02%	256
2021 Q1	$385K	Hold	12,179	–	–	0.02%	240
2020 Q4	$576K	Sell	12,179 -11,719	-49%	-$544K	0.04%	138
2020 Q3	$1.11M	Sell	23,898 -23,898	-50%	-$821K	0.09%	71
2020 Q2	$1.72M	Buy	47,796 +23,898	+100%	+$880K	0.17%	39
2020 Q1	$848K	Sell	23,898 -10,000	-30%	-$409K	0.12%	58
2019 Q4	$1.54M	Hold	33,898	–	–	0.2%	50
2019 Q3	$841K	Buy	+33,898	New	+$849K	0.1%	103

Other funds holding ZYME

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Evoke Wealth's ZYME Position: Q1 2022 in Review

Evoke Wealth sold out of Zymeworks (ZYME) in Q1 2022, closing a stake of 12,179 shares — an estimated $200K sold.

Evoke Wealth first reported a position in ZYME in Q3 2019 and held it in 10 quarters. The position peaked at $1.72M in Q2 2020. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

Evoke Wealth reported no remaining Zymeworks position as of Q1 2022 after selling out during the quarter.
Evoke Wealth sold 12,179 Zymeworks shares in Q1 2022, an estimated $200K.
Evoke Wealth first reported a position in Zymeworks in Q3 2019 and held it in 10 quarters.
Evoke Wealth's Zymeworks position peaked at $1.72M in Q2 2020.
120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on Evoke Wealth's 13F filing for Q1 2022, filed 10 May 2022.